Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.36245196 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.15314431 |
3 | response to peptidoglycan (GO:0032494) | 4.37901870 |
4 | mannose metabolic process (GO:0006013) | 4.00413238 |
5 | pinocytosis (GO:0006907) | 3.92658043 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89510759 |
7 | modulation by symbiont of host defense response (GO:0052031) | 3.89510759 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89510759 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89510759 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89510759 |
11 | modulation by symbiont of host immune response (GO:0052553) | 3.89510759 |
12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79937305 |
13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74407896 |
14 | response to muramyl dipeptide (GO:0032495) | 3.67656090 |
15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65156181 |
16 | detection of other organism (GO:0098543) | 3.58403967 |
17 | cellular extravasation (GO:0045123) | 3.57500699 |
18 | detection of bacterium (GO:0016045) | 3.57487391 |
19 | negative regulation of cell killing (GO:0031342) | 3.56447466 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56447466 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52051736 |
22 | positive regulation of B cell differentiation (GO:0045579) | 3.39031159 |
23 | positive thymic T cell selection (GO:0045059) | 3.38483283 |
24 | neutrophil activation involved in immune response (GO:0002283) | 3.30740844 |
25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24624375 |
26 | B cell receptor signaling pathway (GO:0050853) | 3.21962739 |
27 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.20294039 |
28 | detection of external biotic stimulus (GO:0098581) | 3.10884953 |
29 | negative regulation of granulocyte differentiation (GO:0030853) | 3.06426105 |
30 | pentose-phosphate shunt (GO:0006098) | 3.05444719 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02715402 |
32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01886618 |
33 | macrophage activation involved in immune response (GO:0002281) | 2.93681457 |
34 | regulation of leukocyte degranulation (GO:0043300) | 2.92432015 |
35 | tricarboxylic acid metabolic process (GO:0072350) | 2.91917923 |
36 | immunoglobulin mediated immune response (GO:0016064) | 2.87734694 |
37 | detection of biotic stimulus (GO:0009595) | 2.87678830 |
38 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86792828 |
39 | regulation of mast cell degranulation (GO:0043304) | 2.83405879 |
40 | detection of molecule of bacterial origin (GO:0032490) | 2.82586136 |
41 | thymic T cell selection (GO:0045061) | 2.79944943 |
42 | response to laminar fluid shear stress (GO:0034616) | 2.76560404 |
43 | barbed-end actin filament capping (GO:0051016) | 2.75605832 |
44 | regulation of B cell differentiation (GO:0045577) | 2.72068134 |
45 | urea cycle (GO:0000050) | 2.69821747 |
46 | response to thyroid hormone (GO:0097066) | 2.68218845 |
47 | NADPH regeneration (GO:0006740) | 2.67644450 |
48 | NADH metabolic process (GO:0006734) | 2.67308132 |
49 | stress fiber assembly (GO:0043149) | 2.65878306 |
50 | regulation of necroptotic process (GO:0060544) | 2.65482494 |
51 | response to host (GO:0075136) | 2.65385780 |
52 | response to host defenses (GO:0052200) | 2.65385780 |
53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65385780 |
54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65336568 |
55 | response to host immune response (GO:0052572) | 2.65135538 |
56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65135538 |
57 | negative regulation of necroptotic process (GO:0060546) | 2.65033227 |
58 | regulation of ARF GTPase activity (GO:0032312) | 2.62533628 |
59 | negative regulation of myotube differentiation (GO:0010832) | 2.61715584 |
60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60817698 |
61 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59239419 |
62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.57459691 |
63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56219318 |
64 | creatine metabolic process (GO:0006600) | 2.55532645 |
65 | oxaloacetate metabolic process (GO:0006107) | 2.55297063 |
66 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.53891302 |
67 | urea metabolic process (GO:0019627) | 2.53239871 |
68 | viral transcription (GO:0019083) | 2.51031420 |
69 | respiratory burst (GO:0045730) | 2.50842461 |
70 | regulation of ARF protein signal transduction (GO:0032012) | 2.49083443 |
71 | positive regulation of myotube differentiation (GO:0010831) | 2.48965723 |
72 | regulation of macrophage cytokine production (GO:0010935) | 2.48413802 |
73 | T cell selection (GO:0045058) | 2.48239637 |
74 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.47511121 |
75 | embryonic process involved in female pregnancy (GO:0060136) | 2.47046276 |
76 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45061666 |
77 | complement activation, alternative pathway (GO:0006957) | 2.44341177 |
78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43861425 |
79 | cellular hyperosmotic response (GO:0071474) | 2.43489186 |
80 | myeloid cell activation involved in immune response (GO:0002275) | 2.41294670 |
81 | glucose catabolic process (GO:0006007) | 2.40030004 |
82 | regulation of granulocyte differentiation (GO:0030852) | 2.39224765 |
83 | regulation of monocyte differentiation (GO:0045655) | 2.38576299 |
84 | negative thymic T cell selection (GO:0045060) | 2.38404775 |
85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.37748987 |
86 | positive regulation of Rap GTPase activity (GO:0032854) | 2.37565621 |
87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.35189310 |
88 | regulation of phagocytosis (GO:0050764) | 2.34557955 |
89 | negative regulation of interleukin-12 production (GO:0032695) | 2.32364115 |
90 | nitrogen cycle metabolic process (GO:0071941) | 2.31526909 |
91 | positive regulation of phagocytosis (GO:0050766) | 2.31034631 |
92 | histone H4 deacetylation (GO:0070933) | 2.30875827 |
93 | negative regulation of innate immune response (GO:0045824) | 2.30602095 |
94 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.29951915 |
95 | regulation of extracellular matrix organization (GO:1903053) | 2.29705449 |
96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.28904966 |
97 | peptide catabolic process (GO:0043171) | 2.27788633 |
98 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.26957448 |
99 | germinal center formation (GO:0002467) | 2.26728081 |
100 | modulation by symbiont of host cellular process (GO:0044068) | 2.25683641 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.45207826 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 3.08955443 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57633287 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.47991149 |
5 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.43040590 |
6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36360016 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36179435 |
8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35633370 |
9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33801785 |
10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33691561 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33667515 |
12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32760928 |
13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27540686 |
14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.27280212 |
15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.25258930 |
16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.18236598 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14834045 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12605248 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02916487 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.00825135 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93832388 |
22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89676634 |
23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83852034 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78466221 |
25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77369097 |
26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77362422 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75114480 |
28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73313689 |
29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71741720 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71230005 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68798450 |
32 | MAF_26560356_Chip-Seq_TH2_Human | 1.68666492 |
33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.65428803 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63701797 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63507078 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57585708 |
37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.56980569 |
38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54648449 |
39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52309878 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48266871 |
41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46400193 |
42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45125787 |
43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42934928 |
44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42666313 |
45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40029113 |
46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38603170 |
47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38265469 |
48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37934973 |
49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34726737 |
50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32482453 |
51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30610373 |
52 | P68_20966046_ChIP-Seq_HELA_Human | 1.30033826 |
53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28155530 |
54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28123079 |
55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27567058 |
56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27009473 |
57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26730207 |
58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25836395 |
59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23962749 |
60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22401745 |
61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21492039 |
62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19523346 |
63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19177343 |
64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18397298 |
65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18123605 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17955502 |
67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17908270 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17728377 |
69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16034566 |
70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16007409 |
71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15716585 |
72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13910152 |
73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13646010 |
74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13177723 |
75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12218847 |
76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11778161 |
77 | MYB_26560356_Chip-Seq_TH1_Human | 1.11214366 |
78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11138520 |
79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11079108 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10568467 |
81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09990343 |
82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09911460 |
83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09086553 |
84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08373095 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07612945 |
86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07419786 |
87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06939367 |
88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06526999 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05501011 |
90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05278114 |
91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05161558 |
92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05073281 |
93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04577303 |
94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04094244 |
95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03738574 |
96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03230614 |
97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02758728 |
98 | MYB_26560356_Chip-Seq_TH2_Human | 1.02639180 |
99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01644158 |
100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00891368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 3.75961562 |
2 | MP0003303_peritoneal_inflammation | 3.58163452 |
3 | MP0005058_abnormal_lysosome_morphology | 3.48996251 |
4 | MP0008260_abnormal_autophagy | 2.92428168 |
5 | MP0003172_abnormal_lysosome_physiology | 2.75961921 |
6 | MP0002396_abnormal_hematopoietic_system | 2.54159483 |
7 | MP0003705_abnormal_hypodermis_morpholog | 2.36513317 |
8 | MP0003300_gastrointestinal_ulcer | 2.23814879 |
9 | MP0002419_abnormal_innate_immunity | 2.20222723 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.11580234 |
11 | MP0001835_abnormal_antigen_presentation | 2.08895105 |
12 | MP0005451_abnormal_body_composition | 1.99146697 |
13 | MP0002009_preneoplasia | 1.98374891 |
14 | MP0003828_pulmonary_edema | 1.94069609 |
15 | MP0002132_abnormal_respiratory_system | 1.87997263 |
16 | MP0005464_abnormal_platelet_physiology | 1.87735581 |
17 | MP0005025_abnormal_response_to | 1.85966862 |
18 | MP0009278_abnormal_bone_marrow | 1.85876114 |
19 | MP0001533_abnormal_skeleton_physiology | 1.84787078 |
20 | MP0005000_abnormal_immune_tolerance | 1.72092095 |
21 | MP0000751_myopathy | 1.70009565 |
22 | MP0000685_abnormal_immune_system | 1.68540759 |
23 | MP0001800_abnormal_humoral_immune | 1.66610401 |
24 | MP0003763_abnormal_thymus_physiology | 1.59818186 |
25 | MP0002420_abnormal_adaptive_immunity | 1.57687247 |
26 | MP0005666_abnormal_adipose_tissue | 1.57562376 |
27 | MP0001819_abnormal_immune_cell | 1.56554067 |
28 | MP0003724_increased_susceptibility_to | 1.55726004 |
29 | MP0004808_abnormal_hematopoietic_stem | 1.55314860 |
30 | MP0000858_altered_metastatic_potential | 1.55200634 |
31 | MP0002723_abnormal_immune_serum | 1.54294759 |
32 | MP0009840_abnormal_foam_cell | 1.54015829 |
33 | MP0002452_abnormal_antigen_presenting | 1.50025811 |
34 | MP0010630_abnormal_cardiac_muscle | 1.49437056 |
35 | MP0001853_heart_inflammation | 1.48830707 |
36 | MP0001790_abnormal_immune_system | 1.47866868 |
37 | MP0005387_immune_system_phenotype | 1.47866868 |
38 | MP0000747_muscle_weakness | 1.45674312 |
39 | MP0001545_abnormal_hematopoietic_system | 1.43475999 |
40 | MP0005397_hematopoietic_system_phenotyp | 1.43475999 |
41 | MP0001851_eye_inflammation | 1.42800921 |
42 | MP0004185_abnormal_adipocyte_glucose | 1.42235282 |
43 | MP0002998_abnormal_bone_remodeling | 1.41091975 |
44 | MP0004510_myositis | 1.38106792 |
45 | MP0005670_abnormal_white_adipose | 1.35823500 |
46 | MP0004087_abnormal_muscle_fiber | 1.35406475 |
47 | MP0005330_cardiomyopathy | 1.34578830 |
48 | MP0002398_abnormal_bone_marrow | 1.34262852 |
49 | MP0010155_abnormal_intestine_physiology | 1.31831689 |
50 | MP0004947_skin_inflammation | 1.29383681 |
51 | MP0005076_abnormal_cell_differentiation | 1.27225962 |
52 | MP0001849_ear_inflammation | 1.27071574 |
53 | MP0000716_abnormal_immune_system | 1.26583577 |
54 | MP0006138_congestive_heart_failure | 1.25480957 |
55 | MP0005409_darkened_coat_color | 1.23480514 |
56 | MP0003075_altered_response_to | 1.22906435 |
57 | MP0010368_abnormal_lymphatic_system | 1.22147872 |
58 | MP0000759_abnormal_skeletal_muscle | 1.20377683 |
59 | MP0002139_abnormal_hepatobiliary_system | 1.19602929 |
60 | MP0001661_extended_life_span | 1.18237332 |
61 | MP0002722_abnormal_immune_system | 1.15158248 |
62 | MP0003566_abnormal_cell_adhesion | 1.14292647 |
63 | MP0004036_abnormal_muscle_relaxation | 1.11528435 |
64 | MP0002429_abnormal_blood_cell | 1.11512445 |
65 | MP0000689_abnormal_spleen_morphology | 1.10994847 |
66 | MP0004858_abnormal_nervous_system | 1.09493573 |
67 | MP0002405_respiratory_system_inflammati | 1.08450464 |
68 | MP0000703_abnormal_thymus_morphology | 1.08420112 |
69 | MP0008469_abnormal_protein_level | 1.07749387 |
70 | MP0000733_abnormal_muscle_development | 1.06264019 |
71 | MP0004233_abnormal_muscle_weight | 1.05405358 |
72 | MP0004130_abnormal_muscle_cell | 1.04504927 |
73 | MP0002166_altered_tumor_susceptibility | 1.03545757 |
74 | MP0005375_adipose_tissue_phenotype | 1.03404982 |
75 | MP0001845_abnormal_inflammatory_respons | 1.02865178 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.02453560 |
77 | MP0003690_abnormal_glial_cell | 0.96919736 |
78 | MP0003183_abnormal_peptide_metabolism | 0.94215070 |
79 | MP0002971_abnormal_brown_adipose | 0.93588981 |
80 | MP0004084_abnormal_cardiac_muscle | 0.93519515 |
81 | MP0005390_skeleton_phenotype | 0.92942445 |
82 | MP0006082_CNS_inflammation | 0.91545314 |
83 | MP0000750_abnormal_muscle_regeneration | 0.91443295 |
84 | MP0003453_abnormal_keratinocyte_physiol | 0.91427734 |
85 | MP0000343_altered_response_to | 0.90511395 |
86 | MP0002933_joint_inflammation | 0.90181815 |
87 | MP0009333_abnormal_splenocyte_physiolog | 0.89886004 |
88 | MP0003279_aneurysm | 0.88693182 |
89 | MP0009785_altered_susceptibility_to | 0.88567021 |
90 | MP0003091_abnormal_cell_migration | 0.88177658 |
91 | MP0002148_abnormal_hypersensitivity_rea | 0.84261923 |
92 | MP0002269_muscular_atrophy | 0.83536473 |
93 | MP0005360_urolithiasis | 0.83055156 |
94 | MP0008004_abnormal_stomach_pH | 0.80127983 |
95 | MP0000749_muscle_degeneration | 0.77120196 |
96 | MP0005365_abnormal_bile_salt | 0.76377912 |
97 | MP0009115_abnormal_fat_cell | 0.74871641 |
98 | MP0004883_abnormal_blood_vessel | 0.72202517 |
99 | MP0000604_amyloidosis | 0.71627339 |
100 | MP0008874_decreased_physiological_sensi | 0.70824910 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 3.75355239 |
2 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.49282292 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.29971768 |
4 | Recurrent abscess formation (HP:0002722) | 3.24227098 |
5 | Recurrent bacterial skin infections (HP:0005406) | 3.13809109 |
6 | Colitis (HP:0002583) | 3.08314627 |
7 | Asymmetric septal hypertrophy (HP:0001670) | 3.01781255 |
8 | Obstructive lung disease (HP:0006536) | 2.88574523 |
9 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88574523 |
10 | Abnormality of macrophages (HP:0004311) | 2.84832315 |
11 | Ragged-red muscle fibers (HP:0003200) | 2.84210729 |
12 | Distal lower limb muscle weakness (HP:0009053) | 2.80666987 |
13 | Cellulitis (HP:0100658) | 2.78326205 |
14 | Systemic lupus erythematosus (HP:0002725) | 2.72348350 |
15 | Spontaneous hematomas (HP:0007420) | 2.67658130 |
16 | Dysostosis multiplex (HP:0000943) | 2.66752442 |
17 | Amyloidosis (HP:0011034) | 2.60455393 |
18 | Exercise-induced myalgia (HP:0003738) | 2.56667205 |
19 | Prolonged bleeding time (HP:0003010) | 2.55460570 |
20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51163078 |
21 | Thrombocytosis (HP:0001894) | 2.50750216 |
22 | Gingivitis (HP:0000230) | 2.49352129 |
23 | Increased variability in muscle fiber diameter (HP:0003557) | 2.47123018 |
24 | Abnormality of the fingertips (HP:0001211) | 2.46280633 |
25 | Increased connective tissue (HP:0009025) | 2.44940562 |
26 | Fatigue (HP:0012378) | 2.43446370 |
27 | Myositis (HP:0100614) | 2.42836974 |
28 | Gastrointestinal inflammation (HP:0004386) | 2.41817084 |
29 | Thoracic kyphosis (HP:0002942) | 2.39400653 |
30 | Complement deficiency (HP:0004431) | 2.37069701 |
31 | Abnormality of complement system (HP:0005339) | 2.36797736 |
32 | Deep venous thrombosis (HP:0002625) | 2.35944912 |
33 | Gastrointestinal infarctions (HP:0005244) | 2.34263214 |
34 | Meningitis (HP:0001287) | 2.30719227 |
35 | Inflammation of the large intestine (HP:0002037) | 2.30161091 |
36 | Polycythemia (HP:0001901) | 2.30017023 |
37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26858408 |
38 | Metaphyseal cupping (HP:0003021) | 2.24817188 |
39 | Chest pain (HP:0100749) | 2.24032237 |
40 | Mediastinal lymphadenopathy (HP:0100721) | 2.23951747 |
41 | Epistaxis (HP:0000421) | 2.23909191 |
42 | Recurrent skin infections (HP:0001581) | 2.22733227 |
43 | Abnormality of the thoracic spine (HP:0100711) | 2.22156394 |
44 | Increased cerebral lipofuscin (HP:0011813) | 2.21696306 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.17653218 |
46 | Mucopolysacchariduria (HP:0008155) | 2.16889685 |
47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16889685 |
48 | Increased IgE level (HP:0003212) | 2.14734217 |
49 | Distal lower limb amyotrophy (HP:0008944) | 2.14221163 |
50 | Hypertensive crisis (HP:0100735) | 2.13851162 |
51 | Vertebral compression fractures (HP:0002953) | 2.10787771 |
52 | Cerebral aneurysm (HP:0004944) | 2.09235430 |
53 | Agammaglobulinemia (HP:0004432) | 2.09221683 |
54 | Myopathic facies (HP:0002058) | 2.09051912 |
55 | Hemorrhage of the eye (HP:0011885) | 2.06156924 |
56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02165705 |
57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02165705 |
58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02165705 |
59 | Purpura (HP:0000979) | 1.99325691 |
60 | Polygenic inheritance (HP:0010982) | 1.98623600 |
61 | Progressive muscle weakness (HP:0003323) | 1.97245799 |
62 | Recurrent fungal infections (HP:0002841) | 1.95107276 |
63 | Petechiae (HP:0000967) | 1.94247168 |
64 | Seborrheic dermatitis (HP:0001051) | 1.92418213 |
65 | Ventricular tachycardia (HP:0004756) | 1.91798566 |
66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90469196 |
67 | Obstructive sleep apnea (HP:0002870) | 1.90267960 |
68 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88134913 |
69 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88134913 |
70 | Viral hepatitis (HP:0006562) | 1.87436415 |
71 | Flat acetabular roof (HP:0003180) | 1.86826673 |
72 | Orchitis (HP:0100796) | 1.85689534 |
73 | Recurrent viral infections (HP:0004429) | 1.82441692 |
74 | Gingival bleeding (HP:0000225) | 1.80217353 |
75 | Easy fatigability (HP:0003388) | 1.79424547 |
76 | Abnormality of the lumbar spine (HP:0100712) | 1.79205426 |
77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78964541 |
78 | Neonatal hypoglycemia (HP:0001998) | 1.78559538 |
79 | Difficulty running (HP:0009046) | 1.78158382 |
80 | Rhabdomyolysis (HP:0003201) | 1.77718386 |
81 | Urticaria (HP:0001025) | 1.76102301 |
82 | Broad face (HP:0000283) | 1.74797452 |
83 | Protrusio acetabuli (HP:0003179) | 1.74191977 |
84 | Glomerulonephritis (HP:0000099) | 1.72399629 |
85 | Vasculitis (HP:0002633) | 1.72026648 |
86 | EMG: myopathic abnormalities (HP:0003458) | 1.70013377 |
87 | Reticulocytosis (HP:0001923) | 1.69739772 |
88 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69705397 |
89 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69705397 |
90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69705397 |
91 | Osteomyelitis (HP:0002754) | 1.69643841 |
92 | Dysmetric saccades (HP:0000641) | 1.69164483 |
93 | Abnormality of the periventricular white matter (HP:0002518) | 1.68509961 |
94 | Papilledema (HP:0001085) | 1.67886246 |
95 | Abnormal platelet function (HP:0011869) | 1.67860035 |
96 | Impaired platelet aggregation (HP:0003540) | 1.67860035 |
97 | Slow saccadic eye movements (HP:0000514) | 1.67418160 |
98 | Nemaline bodies (HP:0003798) | 1.66389833 |
99 | Arterial thrombosis (HP:0004420) | 1.65639882 |
100 | Muscle stiffness (HP:0003552) | 1.64544954 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.87291890 |
2 | TRIB3 | 3.71106224 |
3 | PRPF4B | 3.25093285 |
4 | EEF2K | 2.55646351 |
5 | MAP2K3 | 2.54081982 |
6 | MAP4K1 | 2.39638783 |
7 | RIPK4 | 2.24316491 |
8 | FES | 2.17111124 |
9 | SMG1 | 2.12838359 |
10 | TYK2 | 2.03214527 |
11 | FGFR4 | 1.93101675 |
12 | RIPK1 | 1.92207798 |
13 | TTN | 1.82819493 |
14 | ICK | 1.82201300 |
15 | EPHB1 | 1.77872870 |
16 | CDK12 | 1.75215855 |
17 | SIK1 | 1.67258040 |
18 | MAP3K13 | 1.61695589 |
19 | TNK2 | 1.59326426 |
20 | MARK2 | 1.55992829 |
21 | JAK3 | 1.55888382 |
22 | BLK | 1.54019082 |
23 | ZAP70 | 1.41823050 |
24 | TBK1 | 1.32724020 |
25 | MAPK12 | 1.31511171 |
26 | IRAK4 | 1.27645236 |
27 | MAP3K10 | 1.25495414 |
28 | MAP3K7 | 1.17009714 |
29 | BTK | 1.16318670 |
30 | PDK2 | 1.14965082 |
31 | CSK | 1.14099041 |
32 | PTK6 | 1.12693676 |
33 | MAP3K3 | 1.10236037 |
34 | PDPK1 | 1.02834895 |
35 | KSR2 | 1.02466057 |
36 | HCK | 0.98389787 |
37 | IRAK3 | 0.95621631 |
38 | MAP3K1 | 0.95504074 |
39 | RPS6KL1 | 0.92962822 |
40 | RPS6KC1 | 0.92962822 |
41 | ITK | 0.92329215 |
42 | MUSK | 0.89690497 |
43 | TESK2 | 0.89316445 |
44 | JAK1 | 0.88810428 |
45 | SYK | 0.85248968 |
46 | PKN2 | 0.85214061 |
47 | NME2 | 0.85084652 |
48 | TAOK1 | 0.84498377 |
49 | GRK6 | 0.84432903 |
50 | MAPK7 | 0.84220187 |
51 | SIK2 | 0.83759494 |
52 | TAOK2 | 0.82852277 |
53 | PRKD2 | 0.82613896 |
54 | CDC42BPA | 0.80620955 |
55 | DMPK | 0.80450705 |
56 | PDK1 | 0.79484295 |
57 | MAP3K14 | 0.78663787 |
58 | KIT | 0.77856724 |
59 | PASK | 0.77756943 |
60 | JAK2 | 0.77254296 |
61 | MAP3K11 | 0.76076252 |
62 | CDK6 | 0.74489333 |
63 | CSF1R | 0.73168697 |
64 | MTOR | 0.71442169 |
65 | MAPK11 | 0.70362617 |
66 | PDGFRA | 0.69215526 |
67 | PIK3CG | 0.68581535 |
68 | CAMKK1 | 0.68508259 |
69 | RPS6KA2 | 0.68243184 |
70 | RPS6KA6 | 0.66857638 |
71 | CDK4 | 0.66556203 |
72 | MAPKAPK3 | 0.66095616 |
73 | LRRK2 | 0.65178271 |
74 | STK16 | 0.63605401 |
75 | IKBKE | 0.62217318 |
76 | FGFR3 | 0.61579116 |
77 | LCK | 0.60568376 |
78 | LYN | 0.58498027 |
79 | NTRK1 | 0.57183752 |
80 | MATK | 0.56572334 |
81 | PAK4 | 0.55693821 |
82 | MAP3K6 | 0.55546006 |
83 | TEC | 0.55156625 |
84 | BMX | 0.55026252 |
85 | HIPK2 | 0.54780309 |
86 | MAP2K2 | 0.54663820 |
87 | RET | 0.54082341 |
88 | RPS6KB2 | 0.53611830 |
89 | NLK | 0.50917097 |
90 | KDR | 0.50351552 |
91 | DYRK1B | 0.50174052 |
92 | PRKD1 | 0.49533842 |
93 | MAPK4 | 0.46458339 |
94 | FGR | 0.46140121 |
95 | TGFBR2 | 0.43624759 |
96 | STK4 | 0.43581654 |
97 | TRPM7 | 0.43499833 |
98 | IKBKB | 0.42139104 |
99 | NEK9 | 0.41283806 |
100 | TYRO3 | 0.40997218 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.11467428 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44198230 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35205183 |
4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.18484121 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14022378 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10009893 |
7 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.86054785 |
8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79236967 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78313796 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71606048 |
11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.70053968 |
12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65109127 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60037606 |
14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57217183 |
15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55987549 |
16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52901472 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52224791 |
18 | Tuberculosis_Homo sapiens_hsa05152 | 1.44685131 |
19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43100010 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40950442 |
21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38828599 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 1.35866518 |
23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26561069 |
24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25365951 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24845811 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.21673843 |
27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20475106 |
28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18679488 |
29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16290646 |
30 | Platelet activation_Homo sapiens_hsa04611 | 1.12601077 |
31 | Prion diseases_Homo sapiens_hsa05020 | 1.08915779 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.07976971 |
33 | Lysosome_Homo sapiens_hsa04142 | 1.05779753 |
34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04809981 |
35 | Asthma_Homo sapiens_hsa05310 | 1.04685486 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04546278 |
37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03014327 |
38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02549033 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98909217 |
40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.97004666 |
41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96731373 |
42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94975242 |
43 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94339786 |
44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94218697 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91974731 |
46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91765048 |
47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91696158 |
48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91569938 |
49 | Measles_Homo sapiens_hsa05162 | 0.89412712 |
50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89121681 |
51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88627632 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88416045 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.88407062 |
54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86737078 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86228628 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85619210 |
57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85536165 |
58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83686342 |
59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81518489 |
60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81213564 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80201346 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.78016520 |
63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77486187 |
64 | Amoebiasis_Homo sapiens_hsa05146 | 0.77435804 |
65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76765242 |
66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76536337 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74913941 |
68 | Lysine degradation_Homo sapiens_hsa00310 | 0.73174142 |
69 | Hepatitis C_Homo sapiens_hsa05160 | 0.72955752 |
70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72937286 |
71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72586362 |
72 | Apoptosis_Homo sapiens_hsa04210 | 0.72425411 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72043095 |
74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72043008 |
75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71959087 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70260190 |
77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67551820 |
78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67120867 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66999526 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66484137 |
81 | Malaria_Homo sapiens_hsa05144 | 0.66231589 |
82 | Phagosome_Homo sapiens_hsa04145 | 0.65948281 |
83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64472531 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64244073 |
85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62651474 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62052836 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62052558 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59867694 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.59412802 |
90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57005506 |
91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55146628 |
92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55019041 |
93 | Ribosome_Homo sapiens_hsa03010 | 0.53939192 |
94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53935269 |
95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53396522 |
96 | Legionellosis_Homo sapiens_hsa05134 | 0.51146323 |
97 | Glioma_Homo sapiens_hsa05214 | 0.50865451 |
98 | Focal adhesion_Homo sapiens_hsa04510 | 0.50850146 |
99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49805204 |
100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48675528 |